Skip to content
Screener

Guardian Pharmacy Services GRDN EBITDA margin

EBITDA margin at other companies

CVS Health logo
CVS HealthCVS
3.1%-0.4pp
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
3.9%+0.4pp
Omnicell logo
OmnicellOMCL
10.8%+2.5pp
Cardinal Health logo
Cardinal HealthCAH
1.3%-0.1pp
Cencora logo
CencoraCOR
1.2%0.0pp
Lifecore Biomedical, Inc. logo
Lifecore Biomedical, Inc.LFCR
-7.2%—

Other financials

Income statement

See full
Revenue$351.8M+2.2%
Gross profit$80.0M+17.5%
Operating income$20.6M+64.1%
Net income$21.9M+142%
EPS (diluted)$0.34+143%

Balance sheet

See full
Cash & equivalents$89.8M+377%
Total debt$35.2M+4.6%
Total equity$257.6M+43.4%
Total assets$443.6M+24.5%

Cash flow

See full
Operating cash flow$30.0M+50.6%
CapEx$495.0K-78.0%
Free cash flow$34.1M+69.8%

Valuation

See full
Market cap$2.5B+88.6%
Enterprise value$2.44B+82.4%
P/E37.9×—
P/S1.7×+0.7×

Profitability

See full
Gross margin21.6%+2.0pp
Operating margin5.8%—
Net margin4.5%+2.8pp

Returns & leverage

See full
Return on equity30.1%—
Debt / equity0.1×-0.1×
Current ratio1.7×+0.5×

Where this comes from

Calculated from Guardian Pharmacy Services’s reported figures.

ebitda/total revenue=7.4%

Based on trailing twelve months.

The source filing: Guardian Pharmacy Services’s 10-Q, filed August 6, 2026. Open the filing →

Filed
Aug 6, 2026, 4:17 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-338074

FAQ

What is Guardian Pharmacy Services's EBITDA margin?
Guardian Pharmacy Services (GRDN) reported EBITDA margin of 7.4% in Q2 2026.
What does EBITDA margin mean?
EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.

Ask your AI about Guardian Pharmacy Services's ebitda margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude